BIGG Digital Assets Inc. Reports Financial Results for Q3 2024 | VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. ("BIGG' or the "Company") (TSXV: BIGG, OTCQX: BBKCF, WKN: A2PS9W) a leading innovator in the digital assets... ► Artikel lesen |
Toronto Stock Exchange: BIGG Digital Assets Inc. (BIGG) Opens the Market | Toronto, Ontario--(Newsfile Corp. - September 17, 2024) - Dan Reitzik, Interim CEO, BIGG Digital Assets Inc. ("BIGG Digital Assets" or the "Company") (TSXV: BIGG), and his team joined Dani Lipkin,... ► Artikel lesen |
CSE Bulletin: Delist - BIGG Digital Assets Inc. (BIGG) | Toronto, Ontario--(Newsfile Corp. - le 16 septembre/September 2024) - The common shares of BIGG Digital Assets Inc. will be delisted at the market close today, September 16, 2024. BIGG Digital... ► Artikel lesen |
T2 Biosystems, Inc.: T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. | LEXINGTON, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced... ► Artikel lesen |
T2 Biosystems To Sell Its FDA-Cleared Blood Diagnostics For Detection Of Sepsis-Causing Pathogens | WASHINGTON (dpa-AFX) - T2 Biosystems, Inc. (TTOO) Monday said it has reached a multi-year exclusive U.S. agreement with Cardinal Health (CAH) to sell its FDA-cleared direct-from-blood diagnostics... ► Artikel lesen |
T2 Biosystems, Inc.: T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens | LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes... ► Artikel lesen |